Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

EBACU - European Biotech Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)


Close
11.3
0   0%

Share volume: 5,714
Last Updated: Thu 02 Mar 2023 10:00:00 PM CET

PREVIOUS CLOSE
CHG
CHG%

$11.30
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Performance
5 Days
0.29%
1 Month
0.78%
3 Months
2.28%
6 Months
4.04%
1 Year
4.78%
2 Year
3.00%
Key data
Stock price
$11.30
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$8.98 - $10.75
52 WEEK CHANGE
$0.05
MARKET CAP 
142.006 M
YIELD 
N/A
SHARES OUTSTANDING 
10.400 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$5,904
AVERAGE 30 VOLUME 
$3,508
Company detail
CEO:
Region: US
Website:
Employees: 2
IPO year: -
Issue type:
Market: XNAS
Industry:
Sector:

European Biotech Acquisition Corp. was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus on identifying promising opportunities in the life sciences industry in Europe. The members of the management team are associated with LSP, one of Europe’s largest and most experienced healthcare investment firms.

Recent news